Biotechnology Value Fund L P Now Owns 9.60% of Protagonist Therapeutics (PTGX)
20/3 23:40
Fintel reports that Biotechnology Value Fund L P has filed a 13G form with the SEC disclosing ownership of 5.03MM shares of Protagonist Therapeutics Inc (PTGX). This represents 9.6% of the company....